ALVAX
Price
$23.85
Change
-$0.07 (-0.29%)
Updated
Sep 5 closing price
Net Assets
3.41B
VIVAX
Price
$71.21
Change
-$0.23 (-0.32%)
Updated
Sep 5 closing price
Net Assets
202.84B
Interact to see
Advertisement

ALVAX vs VIVAX

Header iconALVAX vs VIVAX Comparison
Open Charts ALVAX vs VIVAXBanner chart's image
American Beacon Large Cap Value A
Price$23.85
Change-$0.07 (-0.29%)
VolumeN/A
Net Assets3.41B
Vanguard Value Index I
Price$71.21
Change-$0.23 (-0.32%)
VolumeN/A
Net Assets202.84B
ALVAX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ALVAX vs. VIVAX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALVAX is a StrongBuy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 203B vs. ALVAX (3.41B). VIVAX pays higher dividends than ALVAX: VIVAX (1.99) vs ALVAX (1.69). ALVAX was incepted earlier than VIVAX: ALVAX (15 years) vs VIVAX (33 years). ALVAX (1.01) is less costly to investors than VIVAX (0.17). ALVAX is a more actively managed with annual turnover of: 26.00 vs. VIVAX (9.00). ALVAX has a lower initial minimum investment than VIVAX: ALVAX (2500) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 7.74 vs. ALVAX (-2.00). VIVAX return over 5 years is better than : 70.18 vs. ALVAX (18.63).
ALVAXVIVAXALVAX / VIVAX
Total Expense Ratio1.010.17594%
Annual Report Gross Expense Ratio1.010.17594%
Fund Existence15 years33 years-
Gain YTD9.1037.845116%
Front Load6%N/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets3.41B203B2%
Annual Yield % from dividends1.691.9985%
Returns for 1 year-2.007.74-26%
Returns for 3 years12.8936.6335%
Returns for 5 years18.6370.1827%
Returns for 10 years5.28131.644%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LYFAX13.300.22
+1.68%
AlphaCentric Life Sciences & Hlthcare A
VGPMX17.010.21
+1.25%
Vanguard Global Capital Cycles Investor
JHUKX37.150.40
+1.09%
JPMorgan Emerging Markets Equity R4
CRCRX9.780.08
+0.82%
NYLI CBRE Real Estate Class C
CMIDX22.440.16
+0.72%
Congress Mid Cap Growth Retail